Ulcerative Colitis Treatments

Find Ulcerative Colitis Treatments

Living with Ulcerative Colitis (UC) is a challenging journey marked by unpredictable flare-ups involving abdominal pain, bloody diarrhea, and constant urgency. This chronic condition, which causes inflammation and ulcers in the lining of the large intestine, profoundly affects a person’s physical and emotional well-being, often dictating daily routines and limiting social activities. The goal of treatment is to control inflammation, alleviate symptoms, and achieve remission, or a prolonged period without active disease.

Treatment is essential to prevent complications such as malnutrition, severe bleeding, and damage to the intestinal wall. UC symptoms and treatment needs vary widely depending on the extent and severity of the inflammation, ranging from mild disease limited to the rectum to severe disease affecting the entire colon. Medication choices are based on the individual’s history and how their immune system responds to different drug classes (Crohn’s & Colitis Foundation, 2022).

Overview of treatment options for Ulcerative Colitis

The overall approach to treating Ulcerative Colitis follows a stepped strategy, moving from milder, localized therapies to stronger systemic medications. The main goals are twofold: to induce remission (stop a flare-up) and to maintain remission (prevent future flares).

Medications are the primary therapy for UC. They target the underlying, inappropriate immune response that causes inflammation. While diet and lifestyle changes are supportive, they do not replace the need for prescription drugs. Surgery, which involves removing the colon, is generally reserved as a last resort for severe cases that do not respond to medical therapy or for those facing serious complications. The majority of patients can effectively manage their condition long-term using medication.

Medications used for Ulcerative Colitis

Medication for UC involves several drug classes, often used in combination.

The first-line therapy for most mild to moderate cases is 5-aminosalicylates (5-ASAs), such as mesalamine and sulfasalazine. These drugs reduce inflammation directly in the lining of the colon and are crucial for maintaining remission. They can be taken orally or administered rectally (via enema or suppository) for localized disease.

For moderate to severe flare-ups, Corticosteroids (like prednisone or budesonide) are used short-term to quickly suppress inflammation. They are effective for inducing remission but are generally not used for long-term maintenance due to significant side effects.

If UC does not respond to 5-ASAs or is severe from the start, doctors turn to Immunomodulators (such as azathioprine or mercaptopurine) and Biologic Therapies. Biologics, including drugs that target TNF (tumor necrosis factor), often represent the most potent class of treatment. These newer drugs are used for moderate to severe disease when conventional therapy has failed.

How these medications work

The major drug classes for UC work by controlling the overactive immune system, which mistakenly attacks the lining of the colon.

5-ASAs deliver an anti-inflammatory compound directly to the colon wall, reducing irritation at the cellular level. They are effective because they work right where the inflammation is located. Corticosteroids are broad-spectrum immunosuppressants that quickly reduce immune activity throughout the body, providing rapid, powerful relief during acute flares.

Immunomodulators and Biologics act much more specifically. Immunomodulators broadly suppress the immune system’s production of inflammatory cells. Biologics are specially engineered proteins that block specific chemical messengers (like TNF-alpha or interleukins) that drive the inflammatory process. By stopping these targeted chemical signals, they prevent the chronic cycle of inflammation that damages the colon (National Institute of Diabetes and Digestive and Kidney Diseases, 2023).

Side effects and safety considerations

UC medications have potential side effects requiring regular follow-up. 5-ASAs commonly cause nausea, headache, or stomach upset. Potent corticosteroids can lead to insomnia, mood swings, weight gain, and higher infection risk with long-term use.

Immunomodulators and Biologics demand strict safety monitoring, including routine blood tests, as they suppress the immune system and increase the risk of serious infections. These drugs are generally contraindicated for patients with active infections or certain cancers. Seek immediate medical attention for severe, persistent fever, sudden vision changes, or signs of a serious allergic reaction.

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. American College of Gastroenterology. https://gi.org
  2. Crohn’s & Colitis Foundation. https://www.crohnscolitisfoundation.org
  3. Mayo Clinic. https://www.mayoclinic.org
  4. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov

Medications for Ulcerative Colitis

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Ulcerative Colitis.

Found 25 Approved Drugs for Ulcerative Colitis

Infliximab

Brand Names
Avsola, Inflectra, Remicade, Renflexis, Zymfentra

Infliximab

Brand Names
Avsola, Inflectra, Remicade, Renflexis, Zymfentra
AVSOLA is a tumor necrosis factor (TNF) blocker indicated for: Crohn's Disease : reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.

Mesalamine

Brand Names
Apriso, Canasa, Lialda, Pentasa, Rowasa, sfRowasa Sulfite-Free

Mesalamine

Brand Names
Apriso, Canasa, Lialda, Pentasa, Rowasa, sfRowasa Sulfite-Free
APRISO ® is indicated for the maintenance of remission of ulcerative colitis in adults. APRISO is an aminosalicylate indicated for the maintenance of remission of ulcerative colitis in adults. ( 1 )

Sulfasalazine

Brand Names
Azulfidine, Azulfidine EN-tabs

Sulfasalazine

Brand Names
Azulfidine, Azulfidine EN-tabs
AZULFIDINE Tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis.

Ustekinumab

Brand Names
Otulfi, Pyzchiva, Selarsdi, Starjemza, Stelara, Steqeyma, Ustekinumab-AAUZ, Ustekinumab-aekn, Ustekinumab-TTWE, Wezlana, Yesintek

Ustekinumab

Brand Names
Otulfi, Pyzchiva, Selarsdi, Starjemza, Stelara, Steqeyma, Ustekinumab-AAUZ, Ustekinumab-aekn, Ustekinumab-TTWE, Wezlana, Yesintek
OTULFI is a human interleukin-12 and -23 antagonist indicated for the treatment of: Adult patients with: moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy.

Adalimumab

Brand Names
Adalimumab-aacf, Humira

Adalimumab

Brand Names
Adalimumab-aacf, Humira
Adalimumab-aacf is a tumor necrosis factor (TNF) blocker indicated for: Rheumatoid Arthritis (RA).
Showing 1-5 of 25
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances